Australia markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9000-0.1100 (-5.47%)
At close: 04:00PM EST
1.9100 +0.01 (+0.53%)
After hours: 07:14PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.0100
Bid0.0000 x 3200
Ask0.0000 x 21500
Day's range1.9000 - 2.0307
52-week range1.3800 - 7.3300
Avg. volume5,787,603
Market cap474.029M
Beta (5Y monthly)1.01
PE ratio (TTM)N/A
EPS (TTM)-1.5420
Earnings date27 Feb 2023 - 03 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.25
  • PR Newswire

    INOVIO Provides an Update on Lassa Fever and MERS Programs

    INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, today announced that it has agreed with its collaborator, the Coalition for Epidemic Preparedness Innovations (CEPI), to discontinue development of product candidates targeting Lassa Fever (INO-4500) and Middle East Respiratory Syndrome (MERS) (INO-4700), following initial analyses of data from studies condu

  • Motley Fool

    3 Stocks to Avoid Right Now

    Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective.

  • Motley Fool

    Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript

    Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO)Q3 2022 Earnings CallNov 08, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day and welcome to the Inovio third quarter 2022 results conference call.